Bioluminescence

Biosafety testing
#Advanced Therapy Medicinal Products (ATMPs) #Bioluminescence #Biosafety testing #Cell and gene therapy #Microbiology #QA/QC

Enhancing rapid microbiology QC in cell & gene therapy

Dr Jeff Domsic, Product Manager Charles River Laboratories, discusses ATP-bioluminescence testing aligned with new regulatory guidelines. Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to developing, manufacturing, administering, and treating diseases. These advanced modalities show significant promise and introduce various safety… Read More

#Exclusive Content #Opinion